UnknownNot Applicable

Gene Expression Profiles in Patients With Permanent Atrial Fibrillation (AF) Versus Sinus Rhythm (SR)

Turkey (Türkiye)60 participantsStarted 2008-12

Plain-language summary

The aim of this project is to determine the morphological criteria of apoptosis in atrial tissues of patients with AF versus SR at transcriptome and genomic size.

Who can participate

Age range

18 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with permanent atrial fibrillation or sinus rhythm and degenerative mitral valve regurgitation who require cardiac surgery * Pulmonary hypertension (systolic PA \> 45 mmHg) * Left ventricular ejection fraction \> 30% Exclusion Criteria: * Paroxysmal AF or atrial flutter * Second or third degree heart block * Permanent pacemaker * Wolff-Parkinson-White syndrome * Brugada syndrome * Ischemic or rheumatic mitral valve disease * Dilated cardiomyopathy * LVEF \< 30% * Infective endocarditis, myocarditis * Trauma * Active HBV, HCV, HIV infection * Chronic renal failure * Autoimmune diseases * Vasculitis * Known genetic disorders

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Expression profiles of genes related to apoptosis

Timeframe: 6 months

Trial details

NCT IDNCT00970034

SponsorAnkara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Contact for this trial

RUCHAN AKAR, Assoc. Prof.

+905336460684 akarruchan@gmail.com

View on ClinicalTrials.gov More Mitral Regurgitation trials

Who can participate

Age range

18 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.